2017-03-09 17:35:23 UTC

Announcing New Crohn’s & Colitis Congress

March 9, 2017

AGA and the Crohn’s & Colitis Foundation are joining together to put on a must-attend IBD conference January 2018 in Las Vegas.

AGA and the Crohn’s & Colitis Foundation are partnering to co-sponsor a new annual conference for health-care professionals and researchers. By joining the nation’s leading IBD patient organization with the premier GI professional organization, this will be the must-attend IBD conference, bringing state-of-the-art comprehensive care together with the latest research to advance prevention, treatment and cures for IBD patients.

The Congress will take place Jan. 18-20, 2018, in Las Vegas. Get ready to expand your knowledge, network with other leaders, and be inspired! 

Registration for the Crohn's & Colitis Congress is now open. Visit our website to learn more and register.

More on Crohn's Disease

Crohn's & Colitis Congress™ (A Partnership of the Crohn's & Colitis Foundation and American Gastroenterological Association)

Jan. 18, 2018

Expand your knowledge, network with IBD leaders, spark innovative research and get inspired to improve patient care.

Association Between Low Trough Levels of Vedolizumab During Induction Therapy for Inflammatory Bowel Diseases and Need for Additional Doses Within 6 Months

Oct. 22, 2017

We investigated whether serum trough levels of vedolizumab, during the induction phase can determine whether patients need additional doses within 6 months.

Healing of Tonsillar Crohn’s Disease With Infliximab

Oct. 22, 2017